NCT00001481View on ClinicalTrials.gov

The Role of Hormones in Postpartum Mood Disorders

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 26, 1996

Primary Completion Date

October 25, 2024

Study Completion Date

October 25, 2024

Conditions
Postpartum Depression
Interventions
DRUG

Estradiol

To determine whether it is abrupt withdrawal or prolonged exposure to gonadal steroids that is associated with PPD.

OTHER

Placebo

To determine whether it is abrupt withdrawal or prolonged exposure to gonadal steroids that is associated with PPD.

DRUG

Progesterone

To determine whether it is abrupt withdrawal or prolonged exposure to gonadal steroids that is associated with PPD.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00001481 - The Role of Hormones in Postpartum Mood Disorders | Biotech Hunter | Biotech Hunter